RS63699B1 - Upotreba sulkardina za tretman atrijalne fibrilacije - Google Patents

Upotreba sulkardina za tretman atrijalne fibrilacije

Info

Publication number
RS63699B1
RS63699B1 RS20220986A RSP20220986A RS63699B1 RS 63699 B1 RS63699 B1 RS 63699B1 RS 20220986 A RS20220986 A RS 20220986A RS P20220986 A RSP20220986 A RS P20220986A RS 63699 B1 RS63699 B1 RS 63699B1
Authority
RS
Serbia
Prior art keywords
composition
use according
pharmaceutically acceptable
dose
sulcardine
Prior art date
Application number
RS20220986A
Other languages
English (en)
Serbian (sr)
Inventor
Gary T Elliot
Yiping Wang
Donglu Bai
Original Assignee
Huyabio International Llc
Shanghai Institute Of Materia Medica Chinese Academy Of Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huyabio International Llc, Shanghai Institute Of Materia Medica Chinese Academy Of Sciences filed Critical Huyabio International Llc
Publication of RS63699B1 publication Critical patent/RS63699B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
RS20220986A 2009-11-17 2010-11-16 Upotreba sulkardina za tretman atrijalne fibrilacije RS63699B1 (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26192509P 2009-11-17 2009-11-17
EP17182709.0A EP3311810B1 (en) 2009-11-17 2010-11-16 Use of sulcardine for the treatment of atrial fibrillation

Publications (1)

Publication Number Publication Date
RS63699B1 true RS63699B1 (sr) 2022-11-30

Family

ID=44060290

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20220986A RS63699B1 (sr) 2009-11-17 2010-11-16 Upotreba sulkardina za tretman atrijalne fibrilacije

Country Status (10)

Country Link
US (1) US8541464B2 (cg-RX-API-DMAC10.html)
EP (2) EP3311810B1 (cg-RX-API-DMAC10.html)
JP (2) JP6116908B2 (cg-RX-API-DMAC10.html)
CN (3) CN102665714A (cg-RX-API-DMAC10.html)
DK (2) DK3311810T3 (cg-RX-API-DMAC10.html)
ES (2) ES2644818T3 (cg-RX-API-DMAC10.html)
HU (2) HUE060876T2 (cg-RX-API-DMAC10.html)
PL (2) PL2501381T3 (cg-RX-API-DMAC10.html)
RS (1) RS63699B1 (cg-RX-API-DMAC10.html)
WO (1) WO2011062906A2 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8541464B2 (en) * 2009-11-17 2013-09-24 HUYA Biosciences International LLC Treatment of atrial fibrillation
WO2011062903A2 (en) * 2009-11-17 2011-05-26 Elliott Gary T Slow infusion of sulcardine and its salts
SG2013035662A (en) 2013-05-08 2014-12-30 Menicon Singapore Pte Ltd Systems and methods for printing on a contact lens
WO2020123824A1 (en) 2018-12-13 2020-06-18 Huya Bioscience International, Llc Sulcardine administration for treatment of acute atrial fibrillation
KR102405199B1 (ko) * 2019-01-29 2022-06-02 후야 바이오사이언스 인터내셔널 엘엘씨 설카딘 염
CN112516136B (zh) * 2019-09-17 2024-03-01 中国科学院上海药物研究所 硫酸舒欣啶在制备抗心衰产品中的应用
US11813245B2 (en) * 2020-06-12 2023-11-14 Huyabio International, Llc Sulcardine administration for treatment of acute atrial fibrillation
CN114984004B (zh) * 2022-05-25 2023-09-12 扬州中宝药业股份有限公司 硫酸舒欣啶在制备抗脓毒症药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1172908C (zh) * 1999-12-10 2004-10-27 中国科学院上海药物研究所 N-取代苄基或苯基芳香磺酰胺化合物及其用途
CN1939298A (zh) * 2005-09-29 2007-04-04 中国科学院上海药物研究所 硫酸舒欣啶固体和靶向制剂及其制备方法
US8541464B2 (en) * 2009-11-17 2013-09-24 HUYA Biosciences International LLC Treatment of atrial fibrillation
WO2011062903A2 (en) * 2009-11-17 2011-05-26 Elliott Gary T Slow infusion of sulcardine and its salts

Also Published As

Publication number Publication date
US8541464B2 (en) 2013-09-24
JP2013511473A (ja) 2013-04-04
JP6116908B2 (ja) 2017-04-19
EP3311810B1 (en) 2022-07-27
DK3311810T3 (da) 2022-10-24
WO2011062906A8 (en) 2012-02-09
CN105362264A (zh) 2016-03-02
HK1254495A1 (en) 2019-07-19
WO2011062906A9 (en) 2011-10-06
WO2011062906A2 (en) 2011-05-26
PL3311810T3 (pl) 2022-12-05
JP2016028054A (ja) 2016-02-25
ES2644818T3 (es) 2017-11-30
PL2501381T3 (pl) 2018-02-28
CN104324024A (zh) 2015-02-04
EP2501381A2 (en) 2012-09-26
CN102665714A (zh) 2012-09-12
EP2501381A4 (en) 2013-06-12
HUE034007T2 (en) 2018-01-29
US20120309810A1 (en) 2012-12-06
HUE060876T2 (hu) 2023-04-28
EP3311810A1 (en) 2018-04-25
DK2501381T3 (da) 2017-11-06
EP2501381B1 (en) 2017-07-26
ES2929185T3 (es) 2022-11-25

Similar Documents

Publication Publication Date Title
EP3311810B1 (en) Use of sulcardine for the treatment of atrial fibrillation
JP6173391B2 (ja) サルカルディン及びその塩の緩速点滴
JP2021519764A (ja) 線維性疾患を処置する方法
JP2013511473A5 (cg-RX-API-DMAC10.html)
JP2022514537A (ja) 急性心房細動の処置のためのサルカルディン投与
JP2013511472A5 (cg-RX-API-DMAC10.html)
CA2524034A1 (en) Uses of ion channel modulating compounds
JP2720348B2 (ja) 脳細胞機能障害改善剤
KR20230024347A (ko) 급성 심방 세동의 치료를 위한 설카르딘 투여
HK1254495B (en) Use of sulcardine for the treatment of atrial fibrillation
EP0303357B1 (en) 4-Amino-6,7-dimethoxy-2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinol-2-yl)quinoline for (treatment of cardiac arrhythmias).
HK1176859B (en) Treatment of atrial fibrillation
HK1176859A (en) Treatment of atrial fibrillation
JP2006528155A (ja) 3,7−ジアザビシクロ[3.3.1]ノナン化合物の、ヒト男性患者の抗不整脈事象治療及び/又は予防のための使用
EA045624B1 (ru) Введение сулькардина для лечения острой фибрилляции предсердий
JPH01283224A (ja) 抗高血圧の組み合わせ調合物
JP2007509865A (ja) 神経障害の治療における選択的オピエート受容体調節物質の使用
US20050054667A1 (en) Method of treating or inhibiting anti-arrhythmic events in male human patients
WO2006053037A2 (en) A new dosing regimen for ion channel modulating compounds for treating acute atrial fibrillation in a human